• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Latest trends in two-dose vaccination against measles among children in the US

Latest trends in two-dose vaccination against measles among children in the US

by Truveta Research | Apr 3, 2025 | Research, Research Insights

The vaccination rate by age six fluctuated between 2018 and 2021; however, rates have decreased since 2021. The rate in 2021 was 81.9% compared to 80.4% in 2024. This means for every 70 children, roughly one more child received two measles vaccines in 2021 compared to...
Latest US first-time measles vaccination trends for children under 24 months

Latest US first-time measles vaccination trends for children under 24 months

by Truveta Research | Apr 3, 2025 | Research, Research Insights

Measles vaccination rates for children under 24 months in 2024 remain lower than in 2020.   In 2024, the average yearly measles vaccination rate for children by 13 months was 58.9% and 68.5% for children by 15 months.   Vaccination patterns for children living in both...

Share this


Recent posts

  • New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization
  • Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns
  • Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice